Skip to main content

Table 3 Procedural characteristics (72 h) and device success (30 days)

From: The association of diabetes mellitus treated with oral antidiabetic drugs and insulin with mortality after transcatheter valve implantation: a 3-year follow-up of the TAVIK registry

 

Without diabetes (n = 1337)

Diabetes on OAD (n = 387)

Diabetes on insulin (n = 276)

p-value

Adjusted OR (95% CI)†

Adjusted p-value†

Device success (n, %)

1196 (89.5)

346 (89.4)

245 (88.8)

0.944

1.10 (0.64–1.91)

0.731

Gradient ≥ 20 mmHg (n, %)

39 (2.9)

14 (3.6)

7 (2.5)

0.228

1.10 (0.64–1.91)

0.731

Moderate or severe aortic insufficiency (n, %)

19 (1.4)

4 (1.0)

3 (1.1)

0.707

0.77 (0.32–1.87)

0.564

Malposition (n, %)

6 (0.4)

0

6 (2.2)

0.079

1.67 (0.52–5.35)

0.391

Second Valve (n, %)

44 (3.3)

14 (3.6)

7 (2.5)

0.607

0.96 (0.56–1.65)

0.881

Procedural mortality 72 h (n, %)

23 (1.7)

8 (2.1)

9 (3.3)

0.685

1.19 (0.62–2.27)

0.598

Early safety (n, %)

1165 (87.1)

326 (84.2)

234 (84.8)

0.258

1.26 (0.96–1.66)

0.096

  1. †Adjustment of significant basic parameters (age, ejection fraction, previous CABG, coronary artery disease, major neurological deficits, renal disease and frailty) between patients with and without DM